Prime

Type your tag names separated by a space and hit enter

Bee-honey and yogurt: a novel mixture for treating patients with vulvovaginal candidiasis during pregnancy.

Abstract

OBJECTIVE

To evaluate the clinical and mycological cure rates of a novel mixture consisting of Bee-honey and yogurt compared to local antifungal agents for treating patients with vulvo-vaginal candidiasis (VVC) during pregnancy.

MATERIALS AND METHODS

This is a prospective comparative study which included 129 patients with VVC during pregnancy. The participants were allocated into study group (n = 82) who received a mixture of Bee-honey and yogurt vaginally and control group (n = 47) who received local anti-fungal agents. The Chi-square test was used to evaluate the clinical and mycological cure rates and the side-effects of both modes of therapy.

RESULTS

The clinical cure rate was significantly higher in the study than the control group (87.8 vs. 72.3%, respectively) while the mycological cure rate was higher in the control than the study group (91.5 vs. 76.9%, respectively). Both types of therapy were favorably tolerated by most of the patients. Side effects were reported only in 24.3 and 29.7% of patients in group I and II, respectively (p < 0.05).

CONCLUSIONS

The mixture of Bee-honey and yogurt produced a high clinical cure rate and a reasonable mycological cure rate. It can be used as a complementary or an alternative to antifungal agents especially in patients with VVC during pregnancy.

Links

  • Publisher Full Text
  • Authors+Show Affiliations

    ,

    Department of Obstetrics and Gynecology, Sohag Faculty of Medicine, Sohag University, Sohag, Egypt, allam30@yahoo.com.

    ,

    Source

    Archives of gynecology and obstetrics 286:1 2012 Jul pg 109-14

    MeSH

    Administration, Intravaginal
    Adult
    Animals
    Bees
    Candida
    Candidiasis, Vulvovaginal
    Female
    Honey
    Humans
    Middle Aged
    Prospective Studies
    Treatment Outcome
    Yogurt

    Pub Type(s)

    Comparative Study
    Evaluation Studies
    Journal Article

    Language

    eng

    PubMed ID

    22314434

    Citation

    TY - JOUR T1 - Bee-honey and yogurt: a novel mixture for treating patients with vulvovaginal candidiasis during pregnancy. AU - Abdelmonem,Allam M, AU - Rasheed,Salah M, AU - Mohamed,Abeer Sh, Y1 - 2012/02/08/ PY - 2011/10/20/received PY - 2012/01/23/accepted PY - 2012/2/9/entrez PY - 2012/2/9/pubmed PY - 2015/12/31/medline SP - 109 EP - 14 JF - Archives of gynecology and obstetrics JO - Arch. Gynecol. Obstet. VL - 286 IS - 1 N2 - OBJECTIVE: To evaluate the clinical and mycological cure rates of a novel mixture consisting of Bee-honey and yogurt compared to local antifungal agents for treating patients with vulvo-vaginal candidiasis (VVC) during pregnancy. MATERIALS AND METHODS: This is a prospective comparative study which included 129 patients with VVC during pregnancy. The participants were allocated into study group (n = 82) who received a mixture of Bee-honey and yogurt vaginally and control group (n = 47) who received local anti-fungal agents. The Chi-square test was used to evaluate the clinical and mycological cure rates and the side-effects of both modes of therapy. RESULTS: The clinical cure rate was significantly higher in the study than the control group (87.8 vs. 72.3%, respectively) while the mycological cure rate was higher in the control than the study group (91.5 vs. 76.9%, respectively). Both types of therapy were favorably tolerated by most of the patients. Side effects were reported only in 24.3 and 29.7% of patients in group I and II, respectively (p < 0.05). CONCLUSIONS: The mixture of Bee-honey and yogurt produced a high clinical cure rate and a reasonable mycological cure rate. It can be used as a complementary or an alternative to antifungal agents especially in patients with VVC during pregnancy. SN - 1432-0711 UR - https://www.unboundmedicine.com/medline/citation/22314434/abstract/Bee_honey_and_yogurt:_a_novel_mixture_for_treating_patients_with_vulvovaginal_candidiasis_during_pregnancy_ L2 - https://dx.doi.org/10.1007/s00404-012-2242-5 ER -